Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$29.88 - $37.04 $1,972 - $2,444
-66 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$25.61 - $35.1 $1,690 - $2,316
66 New
66 $2,000
Q2 2019

Aug 14, 2019

SELL
$62.09 - $86.14 $7.91 Million - $11 Million
-127,457 Closed
0 $0
Q1 2019

May 07, 2019

BUY
$52.92 - $81.17 $335,512 - $514,617
6,340 Added 5.23%
127,457 $10.3 Million
Q4 2018

Feb 12, 2019

BUY
$43.37 - $59.54 $1.39 Million - $1.91 Million
32,017 Added 35.93%
121,117 $6.55 Million
Q2 2018

Aug 10, 2018

SELL
$40.53 - $50.7 $7.9 Million - $9.89 Million
-195,000 Reduced 68.64%
89,100 $3.71 Million
Q1 2018

May 04, 2018

BUY
$44.08 - $55.05 $1.1 Million - $1.38 Million
25,000 Added 9.65%
284,100 $12.5 Million
Q4 2017

Feb 14, 2018

BUY
$50.3 - $64.39 $5,030 - $6,439
100 Added 0.04%
259,100 $13 Million
Q3 2017

Nov 13, 2017

BUY
$45.56 - $59.57 $11.8 Million - $15.4 Million
259,000
259,000 $13.1 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Motley Fool Asset Management LLC Portfolio

Follow Motley Fool Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motley Fool Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motley Fool Asset Management LLC with notifications on news.